CIK: 1547959 - Address: 2000 Sierra Point Parkway, Suite 501, Brisbane, CA 94005
23 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg
S%ret11424-13-25-25-41-16
S%wins25257510010010071

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
6/21/24 19:17
6/21/24
DAWNDay One Biopharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsRamasastry SairaCADS-13213.190-10-2040D
6/12/24 12:21
6/11/24
VIRVir Biotechnology, Inc.DEHealthBioPrdBiological Products, (No DiagRamasastry SairaCADS-4410.950-4-2115D
6/7/24 18:20
6/5/24
MIRMMirum Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsRamasastry SairaCADM.d7114.12050D
6/7/24 18:20
6/5/24
MIRMMirum Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsRamasastry SairaCADS.d-12825.680-5-1000D
6/2/23 12:19
6/1/23
VIRVir Biotechnology, Inc.DEHealthBioPrdBiological Products, (No DiagRamasastry SairaCADS-9025.670-4-2511D
7/13/22 16:05
7/11/22
VIRVir Biotechnology, Inc.DEHealthBioPrdBiological Products, (No DiagRamasastry SairaCADS.d-15030.000-5-388D
5/25/22 17:49
5/24/22
VIRVir Biotechnology, Inc.DEHealthBioPrdBiological Products, (No DiagRamasastry SairaCADS.d-4023.820-2-178D
5/20/21 19:54
5/19/21
VIRVir Biotechnology, Inc.DEHealthBioPrdBiological Products, (No DiagRamasastry SairaCADM.d12812.760100D
5/20/21 19:54
5/19/21
VIRVir Biotechnology, Inc.DEHealthBioPrdBiological Products, (No DiagRamasastry SairaCADS.d-43743.730-10-1000D
12/18/20 19:18
12/17/20
SGMOSangamo Therapeutics, IncDEHealthBioPrdBiological Products, (No DiagRamasastry SairaCADM.d605.9901020015D
12/18/20 19:18
12/17/20
SGMOSangamo Therapeutics, IncDEHealthBioPrdBiological Products, (No DiagRamasastry SairaCADS.d-13313.270-10-4015D
2/27/18 18:41
2/26/18
SGMOSangamo Therapeutics, IncDEHealthBioPrdBiological Products, (No DiagRamasastry SairaCADM.d485.03090D
2/27/18 18:41
2/26/18
SGMOSangamo Therapeutics, IncDEHealthBioPrdBiological Products, (No DiagRamasastry SairaCADS.d-23524.880-9-1000D
11/21/17 17:01
11/17/17
SGMOSangamo Therapeutics, IncDEHealthBioPrdBiological Products, (No DiagRamasastry SairaCADM.d255.03050D
11/21/17 17:01
11/17/17
SGMOSangamo Therapeutics, IncDEHealthBioPrdBiological Products, (No DiagRamasastry SairaCADS.d-7314.670-5-1000D
2/13/15 19:45
2/12/15
SGMOSangamo Biosciences IncDEHealthBioPrdBiological Products, (No DiagRamasastry SairaCADM.d505.0313100D69-151030014192131013-25-47-68
2/13/15 19:45
2/12/15
SGMOSangamo Biosciences IncDEHealthBioPrdBiological Products, (No DiagRamasastry SairaCADS.d-15015.0013-10-1000D69-151030014192131013-25-47-68
8/12/14 20:00
8/8/14
SGMOSangamo Biosciences IncDEHealthBioPrdBiological Products, (No DiagRamasastry SairaCADM.d505.0310100D18042-269-71519717-6-17-8-42
8/12/14 20:00
8/8/14
SGMOSangamo Biosciences IncDEHealthBioPrdBiological Products, (No DiagRamasastry SairaCADS.d-14014.0010-10-1000D18042-269-71519717-6-17-8-42
6/25/14 20:00
6/23/14
SGMOSangamo Biosciences IncDEHealthBioPrdBiological Products, (No DiagRamasastry SairaCADM.d285.031560D19510814-172319-1-304-20-260-28
6/25/14 20:00
6/23/14
SGMOSangamo Biosciences IncDEHealthBioPrdBiological Products, (No DiagRamasastry SairaCADS.d-8615.5315-6-1000D19510814-172319-1-304-20-260-28
3/17/14 20:02
3/17/14
SGMOSangamo Biosciences IncDEHealthBioPrdBiological Products, (No DiagRamasastry SairaCADM.d505.0333100D38014711992191517-13-7-38-31-45-24
3/17/14 20:02
3/17/14
SGMOSangamo Biosciences IncDEHealthBioPrdBiological Products, (No DiagRamasastry SairaCADS.d-23323.2633-10-1000D38014711992191517-13-7-38-31-45-24

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact